FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155493847> ?p ?o ?g. }

• W2155493847 endingPage "829" @default.
• W2155493847 startingPage "822" @default.
• W2155493847 abstract "Aim: The objectives of this study were to evaluate the rate of JC virus (JCV) seroconversion/seroreversion in a French cohort of multiple sclerosis (MS) patients receiving natalizumab (NTZ), describe the characteristics of this population, identify risk factors for JCV seropositivity and analyse the additional value of quantitative JCV serology results in this context. Methods: MS patients from two French MS centres, whose JCV serological status in 2011 while receiving NTZ was known ( n=357; first-generation enzyme-linked immunosorbent assay (ELISA) test (Gen1)), were proposed for inclusion in this study. We evaluated the rate of JCV seroconversion over a period of one year with a second-generation ELISA test (Gen2; n=303) and analysed the quantitative results. Multivariate analysis was performed to identify risk factors for JCV seropositivity. Results: Among the patients with Gen2 JCV serology ( n=303) that had been JCV-seronegative one year before ( n=165), the rate of JCV seroconversion was 26.67% (44/165). We observed a higher proportion of anti-JCV antibody seroconverters (14.5%) than expected (≤3%) but also increasing index values of anti-JCV antibody over time. Conclusion: Our data suggest that JCV reactivation occurs during NTZ therapy and leads to an increase in the anti-JCV antibodies titre, thus making them more easily detectable by the second-generation ELISA test." @default.
• W2155493847 created "2016-06-24" @default.
• W2155493847 creator A5001219883 @default.
• W2155493847 creator A5011728381 @default.
• W2155493847 creator A5014679760 @default.
• W2155493847 creator A5025462803 @default.
• W2155493847 creator A5025528846 @default.
• W2155493847 creator A5048938687 @default.
• W2155493847 creator A5059861916 @default.
• W2155493847 creator A5060570012 @default.
• W2155493847 creator A5063751762 @default.
• W2155493847 creator A5064932437 @default.
• W2155493847 creator A5075141136 @default.
• W2155493847 creator A5080131957 @default.
• W2155493847 date "2013-09-26" @default.
• W2155493847 modified "2023-10-17" @default.
• W2155493847 title "JC-virus seroconversion in multiple sclerosis patients receiving natalizumab" @default.
• W2155493847 cites W1969038254 @default.
• W2155493847 cites W1974438776 @default.
• W2155493847 cites W1986002079 @default.
• W2155493847 cites W1992821990 @default.
• W2155493847 cites W1994381563 @default.
• W2155493847 cites W1995385281 @default.
• W2155493847 cites W1996093516 @default.
• W2155493847 cites W2002855578 @default.
• W2155493847 cites W2024115953 @default.
• W2155493847 cites W2044022462 @default.
• W2155493847 cites W2060597477 @default.
• W2155493847 cites W2069205998 @default.
• W2155493847 cites W2120949040 @default.
• W2155493847 cites W2129925362 @default.
• W2155493847 cites W2140463009 @default.
• W2155493847 cites W2159032161 @default.
• W2155493847 cites W2169676611 @default.
• W2155493847 doi "https://doi.org/10.1177/1352458513505353" @default.
• W2155493847 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24072722" @default.
• W2155493847 hasPublicationYear "2013" @default.
• W2155493847 type Work @default.
• W2155493847 sameAs 2155493847 @default.
• W2155493847 citedByCount "60" @default.
• W2155493847 countsByYear W21554938472014 @default.
• W2155493847 countsByYear W21554938472015 @default.
• W2155493847 countsByYear W21554938472016 @default.
• W2155493847 countsByYear W21554938472017 @default.
• W2155493847 countsByYear W21554938472018 @default.
• W2155493847 countsByYear W21554938472019 @default.
• W2155493847 countsByYear W21554938472020 @default.
• W2155493847 countsByYear W21554938472021 @default.
• W2155493847 countsByYear W21554938472022 @default.
• W2155493847 countsByYear W21554938472023 @default.
• W2155493847 crossrefType "journal-article" @default.
• W2155493847 hasAuthorship W2155493847A5001219883 @default.
• W2155493847 hasAuthorship W2155493847A5011728381 @default.
• W2155493847 hasAuthorship W2155493847A5014679760 @default.
• W2155493847 hasAuthorship W2155493847A5025462803 @default.
• W2155493847 hasAuthorship W2155493847A5025528846 @default.
• W2155493847 hasAuthorship W2155493847A5048938687 @default.
• W2155493847 hasAuthorship W2155493847A5059861916 @default.
• W2155493847 hasAuthorship W2155493847A5060570012 @default.
• W2155493847 hasAuthorship W2155493847A5063751762 @default.
• W2155493847 hasAuthorship W2155493847A5064932437 @default.
• W2155493847 hasAuthorship W2155493847A5075141136 @default.
• W2155493847 hasAuthorship W2155493847A5080131957 @default.
• W2155493847 hasConcept C126322002 @default.
• W2155493847 hasConcept C151730666 @default.
• W2155493847 hasConcept C159047783 @default.
• W2155493847 hasConcept C159654299 @default.
• W2155493847 hasConcept C203014093 @default.
• W2155493847 hasConcept C2777451964 @default.
• W2155493847 hasConcept C2779150272 @default.
• W2155493847 hasConcept C2779343474 @default.
• W2155493847 hasConcept C2780640218 @default.
• W2155493847 hasConcept C2780644213 @default.
• W2155493847 hasConcept C2781004633 @default.
• W2155493847 hasConcept C2908647359 @default.
• W2155493847 hasConcept C45189115 @default.
• W2155493847 hasConcept C71924100 @default.
• W2155493847 hasConcept C86803240 @default.
• W2155493847 hasConcept C99454951 @default.
• W2155493847 hasConceptScore W2155493847C126322002 @default.
• W2155493847 hasConceptScore W2155493847C151730666 @default.
• W2155493847 hasConceptScore W2155493847C159047783 @default.
• W2155493847 hasConceptScore W2155493847C159654299 @default.
• W2155493847 hasConceptScore W2155493847C203014093 @default.
• W2155493847 hasConceptScore W2155493847C2777451964 @default.
• W2155493847 hasConceptScore W2155493847C2779150272 @default.
• W2155493847 hasConceptScore W2155493847C2779343474 @default.
• W2155493847 hasConceptScore W2155493847C2780640218 @default.
• W2155493847 hasConceptScore W2155493847C2780644213 @default.
• W2155493847 hasConceptScore W2155493847C2781004633 @default.
• W2155493847 hasConceptScore W2155493847C2908647359 @default.
• W2155493847 hasConceptScore W2155493847C45189115 @default.
• W2155493847 hasConceptScore W2155493847C71924100 @default.
• W2155493847 hasConceptScore W2155493847C86803240 @default.
• W2155493847 hasConceptScore W2155493847C99454951 @default.
• W2155493847 hasIssue "7" @default.
• W2155493847 hasLocation W21554938471 @default.
• W2155493847 hasLocation W21554938472 @default.

• next